Table 3.
Distribution of 192 patients by PS and by Phase I patient group a
| PS | Phase I patient group | Total | ||
|---|---|---|---|---|
| PC | PE | PT | ||
| 0 | 8 | 0 | 16 | 24 |
| (8%) | (0%) | (18%) | ||
| 1 | 47 | 3 | 64 | 114 |
| (47%) | (75%) | (73%) | ||
| 2 | 22 | 1 | 8 | 31 |
| (22%) | (25%) | (9%) | ||
| 3 | 21 | 0 | 0 | 21 |
| (21%) | (0%) | (0%) | ||
| 4 | 2 | 0 | 0 | 2 |
| (2%) | (0%) | (0%) | ||
| Total | 100 | 4 | 88 | 192 |
PS was unknown for 24 of the 216 patients. Percentages shown are of the column totals.
Patients considered (PC) but not enrolled; patients enrolled (PE) but not treated; and patients treated (PT).